User profiles for C. Levi

Christopher Levi

- Verified email at health.nsw.gov.au - Cited by 108454

Carlos G. Levi

- Verified email at ucsb.edu - Cited by 16429

Carolina Levis

- Verified email at posgrad.ufsc.br - Cited by 5021

Materials design for the next generation thermal barrier coatings

DR Clarke, CG Levi - Annual review of materials research, 2003 - annualreviews.org
… Indeed, in the majority of materials examined after failures above about 1000C, the aluminum
concentration, although depleted somewhat, has not fallen to the critical value (7). Similarly …

Emerging materials and processes for thermal barrier systems

CG Levi - Current Opinion in Solid State and Materials Science, 2004 - Elsevier
… Indeed, thermal conductivities ranging from ∼1.1 to ∼1.7 W/mK at temperatures between
700 and 1200 C have been reported for zirconates of Gd, Eu, Sm, Nd and La [82], [83], [88], [89…

Extending thrombolysis to 4· 5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data

…, CR Levi, C Hsu, TJ Kleinig, M Fatar, D Leys, C Molina… - The Lancet, 2019 - thelancet.com
Background Stroke thrombolysis with alteplase is currently recommended 0–4·5 h after
stroke onset. We aimed to determine whether perfusion imaging can identify patients with …

Conversations with Claude Lévi-Strauss

C Lévi-Strauss, D Eribon - 1991 - philpapers.org
… between Claude Lévi-Strauss … in Lévi-Strauss's candid appraisals of some of the best-known
figures of the Parisian intelligentsia: surrealists André Breton and Max Ernst, with whom Lévi

[HTML][HTML] Endovascular therapy for ischemic stroke with perfusion-imaging selection

…, M Brooks, MA Simpson, F Miteff, CR Levi… - … England Journal of …, 2015 - Mass Medical Soc
Background Trials of endovascular therapy for ischemic stroke have produced variable
results. We conducted this study to test whether more advanced imaging selection, recently …

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

SM Davis, GA Donnan, MW Parsons, C Levi… - The Lancet …, 2008 - thelancet.com
Background Whether intravenous tissue plasminogen activator (alteplase) is effective beyond
3 h after onset of acute ischaemic stroke is unclear. We aimed to test whether alteplase …

[HTML][HTML] Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke

…, MW Parsons, L Churilov, CR Levi, C Hsu… - … England Journal of …, 2019 - Mass Medical Soc
Background The time to initiate intravenous thrombolysis for acute ischemic stroke is generally
limited to within 4.5 hours after the onset of symptoms. Some trials have suggested that …

Persistent effects of pre-Columbian plant domestication on Amazonian forest composition

C Levis, FRC Costa, F Bongers, M Peña-Claros… - Science, 2017 - science.org
The extent to which pre-Columbian societies altered Amazonian landscapes is hotly debated.
We performed a basin-wide analysis of pre-Columbian impacts on Amazonian forests by …

[HTML][HTML] A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

…, G Bateman, G Donnan, S Davis, C Levi - New England journal …, 2012 - Mass Medical Soc
Background Intravenous alteplase is the only approved treatment for acute ischemic stroke.
Tenecteplase, a genetically engineered mutant tissue plasminogen activator, is an …

[HTML][HTML] Tenecteplase versus alteplase before thrombectomy for ischemic stroke

…, T Wijeratne, T Ang, F Miteff, CR Levi… - … England Journal of …, 2018 - Mass Medical Soc
Background Intravenous infusion of alteplase is used for thrombolysis before endovascular
thrombectomy for ischemic stroke. Tenecteplase, which is more fibrin-specific and has longer …